I'm trying to find the "competitor"
a bit tough
one might be cirmtuzumab, which got orphan drug status in June
its possible that its one of those get it off the market plays
results for that company drug came out today also https://seekingalpha.com/news/3632323-new-data-on-lead-drug-propels-oncternal-therapeutics-up-78https://seekingalpha.com/news/3632323-new-data-on-lead-drug-propels-oncternal-therapeutics-up-78
which is odd because that Merck take-over would have to have started to be orchestrated some time ago
I'm trying to find the "competitor" a bit tough one might be...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |